Luxembourg vs Small island developing States (SIDS): Proportion of the target population who received the final dose of
Luxembourg
79.0%
in 2024
Small island developing States (SIDS)
22.0%
in 2024
Luxembourg rank
24th
Small island developing States (SIDS) rank
25th
Proportion of the target population who received the final dose of over time
- Luxembourg
- Small island developing States (SIDS)
How they compare
Luxembourg currently reports 79.0% against 22.0% in Small island developing States (SIDS), a difference of 57.0%.
That makes Luxembourg's figure about 3.6 times Small island developing States (SIDS)'s.
Across all 15 years both countries report, Luxembourg has been ahead every year.
Luxembourg ranks 24th and Small island developing States (SIDS) ranks 25th of 107 countries.
Luxembourg has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Luxembourg | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 25.5% | 3.6% | 21.9% | Luxembourg |
| 2020s | 75.2% | 13.2% | 62.0% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Luxembourg or Small island developing States (SIDS)?
- Luxembourg, at 79.0% against 22.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Luxembourg and Small island developing States (SIDS)?
- 57.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Small island developing States (SIDS)?
- 15 years are reported by both, from 2010 to 2024.
- How do Luxembourg and Small island developing States (SIDS) rank globally for proportion of the target population who received the final dose of?
- Luxembourg ranks 24th and Small island developing States (SIDS) ranks 25th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.